rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

BriaCell Therapeutics Corp. - Common Shares

BCTX · Nasdaq

Health CareBiotechnologyNot moving yet

BCTX stood above a rising 150-day average in 1 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 9.2% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 1
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
17 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 1 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders17+3 on the quarter
New · exited2 · 0
Reported value$1.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Cable Car Capital, LPunchanged · filed 14 Aug 2026216,821$703K00.0%
SABBY MANAGEMENT, LLCadded · filed 14 Aug 202680,721$262K+6,806+9.2%
IRIDIAN ASSET MANAGEMENT LLCunchanged · filed 29 Jul 202665,000$211K00.0%
UBS Group AGadded · filed 13 Aug 202643,642$141K+32,101+278.1%
JANE STREET GROUP, LLCnew · filed 14 Aug 202626,515$86K+26,515
LuminArx Capital Management LPunchanged · filed 14 Aug 202615,000$49K00.0%
NATIONAL BANK OF CANADAadded · filed 10 Aug 20261,803$5,796+1,001+124.8%
MORGAN STANLEYreduced · filed 13 Aug 20261,033$3,347-1,988−65.8%
Federation des caisses Desjardins du Quebecreduced · filed 14 Aug 2026450$1,444-5−1.1%
Allworth Financial LPunchanged · filed 11 Aug 2026100$32400.0%
30 Sep 2025 – 30 Jun 2026
121517Sep 25Dec 25Mar 26Jun 26

Everyone who traded it

Marc Lustig Company insiderDirector, 10% owner · last 14 May 20241 · 0
Jamieson Bondarenko Company insiderChairman · last 28 Dec 20222 · 0
William V. Williams Company insiderPresident, CEO · last 23 Dec 20220 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Jul 2025-154%
Share count trendFY 2025 · to 15 Oct 20250.0%
Cash and equivalentsFY 2025 · to 31 Jul 2025$10.5M

Analyst forecasts

No analyst forecasts yet.